| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Mpm Bioventures 2018, L.P. is a 10% Owner at DYN with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $141.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | 10% Owner | Buy | 1,112,777 | $18.00 | $20,029,986.00 | +12.2% | -22.4% | - | |
| Dec 11, 2024 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Sell | 44,722 | $20.51 | $917,110.96 | -0.5% | -46.5% | -45.7% | |
| Nov 2, 2021 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Buy | 100,000 | $20.00 | $2,000,000.00 | +2.3% | -56.6% | -14.1% |